ABSTRACT
Purpose
Our
study
aimed
to
comprehensively
describe
the
features
of
peripheral
blood
multiple
immune
cell
phenotypes
in
solid
tumor
patients
during
pretreatment
and
after
immunotherapy,
providing
a
more
convenient
approach
for
studying
prognosis
immunotherapy
different
patients.
Methods
We
prospectively
recruited
with
advanced
tumors
from
Peking
Union
Medical
College
Hospital
(PUMCH)
between
February
2023
April
2024.
Using
multicolor
flow
cytometry,
our
observed
described
signatures
lymphocyte
subsets
including
activation,
proliferation,
function,
naïve
memory,
T
exhaustion
this
population
immunotherapy.
Results
enrolled
59
healthy
controls
were
matched
by
age
gender.
The
results
demonstrated
marked
upregulation
expression
activation
markers
CD38
HLA‐DR,
as
well
proliferation
PD‐1
Ki67,
compared
controls.
After
checkpoint
blockade
(ICB)
treatment,
mainly
Ki67CD4+T
HLA‐DRCD38CD4+T,
was
significantly
upregulated
levels
(
p
=
0.017,
0.019,
respectively).
further
found
that
gynecological
better
prognoses
had
higher
baseline
CD4+
cells
other
poorer
prognoses.
Conclusion
elucidated
characteristics
Further
research
revealed
changes
ICIs
activated
phenotype
playing
crucial
role
antitumor
effect.
This
lays
groundwork
exploration
prognostic
biomarkers
predictive
models
cancer
Emerging Microbes & Infections,
Год журнала:
2023,
Номер
13(1)
Опубликована: Ноя. 22, 2023
This
review
gives
an
overview
of
the
protective
role
CD8+
T
cells
in
SARS-CoV-2
infection.
The
cross-reactive
responses
intermediated
by
unexposed
cohorts
are
described.
Additionally,
relevance
resident
upper
and
lower
airway
during
infection
is
discussed,
T-cell
following
vaccination,
including
recent
worrisome
breakthrough
infections
variants
concerns
(VOCs).
Lastly,
we
explained
correlation
between
COVID-19
severity.
aids
a
deeper
comprehension
association
broadens
vision
for
future
exploration.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Июнь 17, 2024
Background
Unbalanced
inflammatory
response
is
a
critical
feature
of
sepsis,
life-threatening
condition
with
significant
global
health
burdens.
Immune
dysfunction,
particularly
that
involving
different
immune
cells
in
peripheral
blood,
plays
crucial
pathophysiological
role
and
shows
early
warning
signs
sepsis.
The
objective
to
explore
the
relationship
between
sepsis
subpopulations
identify
patients
higher
risk
28-day
mortality
based
on
immunological
subtypes
machine-learning
(ML)
model.
Methods
Patients
were
enrolled
according
sepsis-3
criteria
this
retrospective
observational
study,
along
age-
sex-matched
healthy
controls
(HCs).
Data
clinical
characteristics,
laboratory
tests,
lymphocyte
immunophenotyping
collected.
XGBoost
k-means
clustering
as
ML
approaches,
employed
analyze
profiles
stratify
septic
their
subtypes.
Cox
regression
survival
analysis
was
used
potential
biomarkers
assess
association
mortality.
accuracy
for
determined
by
area
under
receiver
operating
characteristic
(ROC)
curve
(AUC)
analysis.
Results
study
100
89
HCs,
revealing
distinct
two
groups.
model
discriminated
from
HCs
an
1.0
0.99
training
testing
set,
respectively.
Within
model,
top
three
highest
important
contributions
percentage
CD38
+
CD8
T
cells,
PD-1
NK
HLA-DR
cells.
Two
clusters
conducted.
Cluster
1
featured
proportions
PD1
while
cluster
2
naïve
CD4
Furthermore,
level
significantly
non-survivors
than
survivors
(15.1%
vs
8.6%,
P
<0.01).
Moreover,
levels
combined
SOFA
score
showed
good
performance
predicting
(AUC=0.91,95%CI
0.82–0.99),
which
superior
only(AUC=0.69,
sensitivity
0.74,
specificity
0.64,
cut-off
value
11.25%).
In
multivariate
regression,
high
expression
proportion
related
(aHR=1.34,
95%CI
1.19
1.50;
<0.001).
Conclusion
provides
novel
insights
into
cell
prognosis
Peripheral
could
potentially
those
Clinical and Experimental Medicine,
Год журнала:
2024,
Номер
24(1)
Опубликована: Июнь 18, 2024
Abstract
The
relationship
between
antiphospholipid
syndrome
(APS)
and
acute
viral
infection,
such
as
SARS-CoV-2,
is
unclear.
This
study
aims
to
assess
symptoms,
antibody
(aPL)
fluctuations,
complication
risks
in
APS
patients
infected
with
SARS-CoV-2.
from
Peking
Union
Medical
College
Hospital
during
the
COVID-19
outbreak
(October–December
2022)
were
included.
Age-
gender-matched
without
infection
served
controls.
Data
on
demographics,
treatments,
serum
aPL
levels
analyzed.
Of
234
patients,
107
(45.7%)
Typical
symptoms
included
high
fever
(81.3%),
cough/expectoration
(70.1%),
pharyngalgia
(52.3%).
gender-based
matching
selected
97
either
or
uninfected
group.
After
anti-β-2-glycoprotein
I-IgG
(aβ2GP1-IgG)
increased
4.14
4.18
AU/ml,
aβ2GP1-IgM
decreased
9.85
7.38
anticardiolipin-IgA
(aCL-IgA)
significantly
a
median
remaining
at
2.50
APLU/ml.
Lupus
anticoagulants
other
aPLs
remained
stable.
Arterial
thrombosis
incidence
18
(18.6%)
21
(21.6%),
while
venous
did
not
change.
Additionally,
7
(6.5%)
presented
new-onset
worsening
thrombocytopenia,
characterized
by
significant
decline
platelet
count
(no
less
than
10
×
9
/L)
within
two
weeks
of
SARS-CoV-2
all
which
recovered
2
weeks.
Acute
may
induce
worsen
thrombocytopenia
but
does
substantially
increase
thrombotic
events
APS.
process
was
related
mild
titer
fluctuation
aβ2GP1-IgG,
aCL-IgA
necessitating
careful
monitoring
management.
Immunosenescence
is
a
process
of
immune
dysfunction
that
occurs
along
with
aging.
Many
studies
have
focused
on
the
changes
different
lymphocyte
subsets
in
diseases
and
However,
fluctuation
number
phenotype
subset
caused
by
aging
not
been
comprehensively
analyzed,
especially
effects
new
indicators
such
as
PD-1
Ki67
peripheral
blood
rarely
reported.
We
further
investigated
humoral
cellular
parameters
150
healthy
donors
over
18
years
old.
Age
was
associated
decreased
CD4+CD45RA+CD62L+
T
cells,
CD4+CD45RA+CD31+
increased
memory
CD4+
or
CD8+
dominated
male
cells.
The
loss
CD28
expression
cells
transverse
trend
activated
CD38
HLA-DR
were
also
related
to
age.
In
addition,
men
more
prominent
activation
indicators,
difference
between
old
young
groups
obvious.
CD4+CD25+CD127-
percentage
tended
decrease
age
did
differ
significantly
gender.
Interestingly,
we
found
positively
PD-1+
showed
significant
age-related
variability
men.
Similarly,
CD8+ki-67+
an
increasing
trend,
differences
group
other
elderly
males.
Our
findings
can
provide
immunological
clues
for
future
research,
offering
insights
clinical
monitoring
prevention
certain
diseases.
Frontiers in Microbiology,
Год журнала:
2024,
Номер
15
Опубликована: Июль 15, 2024
To
explore
the
impact
of
donors'
COVID-19
status
on
allogeneic
stem
cell
transplantation
(allo-HSCT),
we
compared
transplant
outcomes
74
participants.
This
multi-center
retrospective
study
included
nine
participants
receiving
grafts
from
positive
donors
(CPD),
45
experienced
(CED),
and
20
naive
(CND).
We
evaluated
engraftment,
complications,
survival
rates
among
three
groups.
All
apheresis
procedures
were
successful
with
no
significant
differences
in
CD34+
cells
or
lymphocytes
patients
achieved
engraftment
by
day
30
post-HSCT.
The
incidence
grade
II-IV
acute
graft-versus-host
disease
(aGVHD)
was
55.6%,
20%,
10%
CPD,
CED,
CND
groups,
respectively
(p
=
0.024).
Multivariate
analysis
indicated
that
positivity
at
time
an
independent
risk
factor
for
aGVHD
0.020,
OR
12.159,
95%
CI
1.783
-135.760).
No
observed
groups
terms
chronic
GVHD,
viral
infection,
sinusoidal
obstruction
syndrome.
6-month
overall
disease-free
also
similar
Our
results
suggest
COVID-19-positive
might
not
graft
collection,
short-term
allo-HSCT
recipients
but
increase
aGVHD.
Further
research
is
needed
to
influence
long-term
complications
recipients.
BMC Infectious Diseases,
Год журнала:
2024,
Номер
24(1)
Опубликована: Авг. 9, 2024
The
current
study
aimed
to
investigate
the
baseline
immune
and
inflammatory
features
in-hospital
outcomes
of
patients
infected
with
Omicron
variant
(PIWO)
who
presented
different
disease
severities
during
first
wave
mass
infections
in
Chinese
population
has
occurred.
European Journal of Medical and Health Research,
Год журнала:
2024,
Номер
2(5), С. 27 - 47
Опубликована: Сен. 1, 2024
This
review
highlights
the
significant
impact
of
SARS-CoV-2
on
hematological
system,
revealing
complications
such
as
thrombocytopenia,
coagulopathy,
venous
thromboembolism
(VTE),
and
hemolytic
anemia,
which
contribute
notably
to
morbidity
mortality,
especially
in
critically
ill
patients.
The
underlying
mechanisms
involve
direct
viral
effects,
inflammation,
cytokine
storms,
hypercoagulability.
exacerbation
pre-existing
malignancies
common
occurrence
lymphopenia
further
illustrate
complex
interaction
between
COVID-19
immune
system.
emphasizes
importance
early
recognition
management
for
clinical
practice.
It
discusses
necessity
monitoring
biomarkers
like
D-dimer
platelet
counts,
utilizing
imaging
techniques
detecting
thromboembolic
events,
employing
timely
interventions
with
anticoagulants
immunomodulators.
Tailoring
treatment
individual
patient
needs
involving
a
multidisciplinary
team
are
essential
improving
outcomes,
particularly
also
focuses
need
ongoing
research
understand
precise
these
complications,
explore
genetic
environmental
factors,
assess
long-term
outcomes
affected
examines
emerging
variants
developing
innovative
therapeutic
approaches,
including
personalized
medicine
advanced
therapies,
address
challenges
medical
Journal of Infection,
Год журнала:
2024,
Номер
89(6), С. 106304 - 106304
Опубликована: Окт. 5, 2024
Severe
coronavirus
disease
2019
(COVID-19)
often
leads
to
acute
respiratory
distress
syndrome
and
multi-organ
dysfunction,
driven
by
a
dysregulated
immune
response,
including
cytokine
storm
with
elevated
proinflammatory
levels.
Natural
killer
(NK)
cells
are
part
of
the
innate
system
fundamental
role
in
defense
against
viral
infections.
However,
during
COVID-19
infection,
they
exhibit
an
altered
phenotype
impaired
functionality
contributing
immunopathogenesis
disease.
In
this
work,
we
have
studied
cohort
patients
(ranging
from
mild
severe)
analyzing
IL-15,
TGF-β,
PlGF
GDF-15
plasma
levels
performing
multiparametric
flow
cytometry
studies.
Our
results
revealed
that
severe
exhibited
high
GDF-15,
along
enrichment
NK
cell
subset
expressing
CD151
tetraspanin,
which
correlated
IL-15
severity.
patients,
these
CD151+
displayed
more
activated
characterized
increased
expression
HLA-DR,
CD38
granzyme
B,
distinct
receptor
repertoire,
lower
CD160
CD31
higher
CD55
and,
remarkably,
tissue-resident
markers
CD103
decidual
marker
CD9.
Last
all,
individuals
disease,
identified
expansion